1 Min Read
April 6 (Reuters) - DiaSorin SpA:
* Receives FDA emergency use authorization for the first, fully-automated Zika IgM Test Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.